News Search Results
Oct 19, 2023, 16:01 ET Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus
the opportunity to take advantage of incentives to access Ginkgo's platform. By offering flexible services, Ginkgo aims to be the end-to-end synthetic biology R&D partner for companies at BIO4 exploring solutions in pharmaceuticals, food and agriculture, industry, and specialty chemicals. Companies
More news about: Ginkgo Bioworks
Oct 19, 2023, 11:07 ET FDA Clears Rise Therapeutics' IND Application to Initiate a Phase 1 Clinical Study of Its Novel Oral Immunotherapy for the Treatment of Rheumatoid Arthritis
rheumatoid arthritis Phase 1 clinical trial for its program candidate, R-2487. This is Rise Therapeutics' second clinical program developed using synthetic biology and its proprietary oral biologics delivery platform.
More news about: Rise Therapeutics
Oct 19, 2023, 09:00 ET Debut Set to Revolutionize the Fragrance Industry with Proprietary Advanced Biomanufacturing, Closes More Than $40 Million in Additional Series B Funding
DIEGO, Oct. 19, 2023 /PRNewswire/ -- Debut, a vertically integrated synthetic biology company that unlocks a new generation of cosmetic bioactive ingredients using the most advanced biomanufacturing approaches, announced that it
More news about: Debut
Oct 18, 2023, 23:00 ET ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International
of healthcare products; companion animal and livestock health; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology. ERS holds over 100 patents worldwide. For additional information, please visit
More news about: ERS Genomics
Oct 18, 2023, 23:00 ET ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International
of healthcare products; companion animal and livestock health; production of industrial materials such as enzymes, biofuels and chemicals; and synthetic biology. ERS holds over 100 patents worldwide. For additional information, please visit
More news about: ERS Genomics
Oct 18, 2023, 10:15 ET INTRODUCING ZENSO: PIONEERING A MORE SUSTAINABLE FUTURE FOR THE ALCOHOLIC BEVERAGE INDUSTRY THROUGH THE POWER OF BIOTECHNOLOGY
career in 1986 as the founding Head Brewer at The Harpoon Brewery in Boston, MA. After 30+ years of exploring how synthetic biology tools can be used in the alcoholic beverage industry, Heissner founded local Weymouth brewery Barrel House Z
More news about: Zenso Labs
Oct 18, 2023, 08:00 ET Complete Genomics Partners with Integrated DNA Technologies to Establish New Ecosystem of NGS Products
accelerate the pace of genomics, IDT has been enabling genomics laboratories and researchers in high-throughput sequencing, CRISPR genome editing, synthetic biology, digital PCR, RNA interference, and more with its proprietary technologies since 1987. Its relationship with MGI, parent company of Complete Genomics,
More news about: Complete Genomics
Oct 17, 2023, 07:01 ET Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit
BOSTON, Oct. 17, 2023 /PRNewswire/ -- Persephone Biosciences Inc., a synthetic biology company reimagining patient health through the microbiome, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming
More news about: Ginkgo Bioworks
Oct 17, 2023, 04:23 ET By 2032, Global Gout Therapeutics Market Size Projected to Reach USD 6.04 Billion, at 8.1% CAGR Growth: Polaris Market Research
collaboration aims at developing a novel drug candidate for gout treatment. Synlogic Inc. is a clinical-stage biotech firm that uses its novel synthetic biology approach to develop medications targeting metabolic and immunological disorders.What Can the Report Help You Find?
More news about: Polaris Market Research
Oct 16, 2023, 07:01 ET Zenfold Leverages Ginkgo Enzyme Services to Enable Veterinary Active Ingredient Development with Sustainable Biology
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 16, 2023, 07:00 ET Survey data reveals two-thirds of American adults would eat more and pay more for ultra-processed foods that include more nutritious ingredients
provide consumers with confidence in quality and reliability. Ayana Bio has partnered with Ginkgo Bioworks, a synthetic biology platform company that is redesigning the living world to solve some of the globe's growing challenges in health, energy, food, material, and more.
More news about: Ayana Bio
Oct 12, 2023, 08:00 ET Phabuilder Presents "Phamily" at the Go!PHA Congress: A New Era for PHA Materials
"Every PHA moment shapes tomorrow," PhalifeTM represents Phamily in a broader context. Phabuilder is a startup in cutting-edge synthetic biology boasting over three decades of PHA study and advancements in Halomonas generations. With its current funding of $100M USD,
More news about: Beijing Phabuilder Biotechnology Co., Ltd.
Oct 12, 2023, 07:01 ET QL AG Announces Partnership with Ginkgo Bioworks to Develop Dairy Proteins
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 12, 2023, 05:00 ET Aclid Closes Oversubscribed $3.3 Million Seed Funding Round to Advance Biosecurity and Compliance
University Professor of Systems Biology Harris Wang, Ph.D., and Kevin Flyangolts. Bringing together their synthetic biology and engineering backgrounds, they formed Aclid to make genetic engineering safer. About AclidAclid is the security and
More news about: Aclid
Oct 12, 2023, 02:32 ET IDTechEx Reports on White Biotechnology: Key Technology Trends Reshaping Its Growth
least among them their extensive research history, collective knowledge base, and available genetic engineering tools. But even with the tools of synthetic biology, expanded by the likes of Gingko Bioworks, engineered model organisms sometimes face inherent limitations in white biotechnology applications,
More news about: IDTechEx
Oct 11, 2023, 09:00 ET Greentown Go Make 2023 with Shell Announces Startup Cohort
Bio (Portland, Ore., U.S.) is developing a novel synthetic biology platform that uses microbial spores and enzymes to create catalysts that are long-lasting and can withstand extreme conditions and environments.
More news about: Greentown Labs
Oct 11, 2023, 08:30 ET Kyverna Therapeutics Announces FDA Clearance of IND for KYV-101, a Novel Fully Human CD19 CAR T-Cell Therapy to Treat Scleroderma
a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline
More news about: Kyverna Therapeutics
Oct 11, 2023, 08:00 ET Codagenix Announces Late-Breaking Presentation of Positive Clinical Immunogenicity Data For COVID-19 Vaccine Candidate CoviLiv™ at IDWeek 2023
N.Y., Oct. 11, 2023 /PRNewswire/ -- Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, today announced the late-breaking presentation
More news about: Codagenix Inc.
Oct 10, 2023, 08:35 ET Learning Undefeated Receives Three DoD STEM Grant Awards for 2023/24 School Year
from across the spectrum of STEM careers, and explore DoD STEM career opportunities. In addition to advanced biotechnology content, including synthetic biology and gene editing, the four-month program helps students succeed in STEM by increasing their science capital in the areas of knowledge, attitude,
More news about: Learning Undefeated
Oct 10, 2023, 06:57 ET eMerge Americas Celebrates 10 Years of Cultivating Innovation and Transformation
he served as the inaugural keynote speaker for the conference in 2014. Diamandis will share his insights on how powerful technologies such as synthetic biology, cloud computing, AI and robotics, and biotechnology are transforming the innovation landscape. Further distinguished speakers for the 2024 conference
More news about: eMerge Americas
Oct 09, 2023, 08:00 ET bioSeedin Biopharma Developer Innovation Conference Held to Accelerate Global Pharmaceutical Innovation and Collaboration
WestLake University, and the other one themed "'Discovery and preparation of small molecule drugs' and 'Development trends of innovative drugs and synthetic biology'" by Dawei Ma, an academician of the Chinese Academy of Sciences. Two stimulating panel discussions were led by
More news about: bioSeedin
Oct 05, 2023, 07:00 ET Concentric by Ginkgo to Support CDC-Funded Consortium to Develop New AI-Based Technologies for Epidemic Forecasting
and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Oct 03, 2023, 08:00 ET Codagenix Announces BARDA Contract for Project NextGen Supporting Development of CoviLiv™ as an Intranasal COVID-19 Vaccine
N.Y., Oct. 3, 2023 /PRNewswire/ -- Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, today announced that the Biomedical Advanced
More news about: Codagenix Inc.
Oct 03, 2023, 07:00 ET WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION
Wellness and Food & Beverage industries. Today's announcement marks further progress in broadening the relationship by offering an end-to-end synthetic biology solution and expanding the parties' joint product portfolio.
More news about: Willow Biosciences Inc.
Oct 03, 2023, 03:00 ET WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION
Wellness and Food & Beverage industries. Today's announcement marks further progress in broadening the relationship by offering an end-to-end synthetic biology solution and expanding the parties' joint product portfolio. About WILLOW BIOSCIENCES Willow develops and produces precision
More news about: SUANFARMA